Drug Profile
Research programme: monoclonal antibody therapies - Vaccinex/Five Prime
Alternative Names: Anti-VEGF1/2 monoclonal antibody; VX-18; VX-60; VX-70Latest Information Update: 21 Apr 2021
Price :
$50
*
At a glance
- Originator Vaccinex
- Class Monoclonal antibodies
- Mechanism of Action CD100 antigen inhibitors; Immunomodulators; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cancer
Highest Development Phases
- Discontinued Bacterial infections; Cancer; Viral infections